|
|
Article: DRAXIS Accepted by FDA to Manufacture Solid Dosage Form Products; Approval Opens Doors to Additional Markets in the U.S.
- Article from:
- Business Wire
- Article date:
- September 17, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Sept. 17, 2002
DRAXIS Health Inc. (TSX:DAX) (NASDAQ:DRAX) has received a letter of acceptance from the U.S. Food and Drug Administration (FDA) for DRAXIS Pharma Inc., its contract pharmaceutical manufacturing subsidiary, to manufacture solid dosage form products, such as capsules and tablets, for the U.S. market. This FDA acceptance positions DRAXIS Pharma for continuing expansion of its customer base for the production of pharmaceutical products in the U.S. and other international markets.
The notice from the FDA follows an inspection of the Company's ...
Related newspaper, magazine, and journal articles:
|
|
Article: X-ray Microtomography of Solid Dosage Forms
Pharmaceutical Technology;
April 1, 2005 ;
700+ words
... ... understanding of the structural features of solid dosage forms and the changes in those features ... sought the ability to see inside the solid dosage forms they produce to determine their ... visualizing the internal structure of solid dosage forms, including ^sup 1^H NMR imaging ...
|
|